Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11135210 Indane-amines as PD-L1 antagonists

Patent 11135210 was granted and assigned to ChemoCentryx on October, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

ChemoCentryx

Current Assignee

ChemoCentryx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

111352100

Patent Inventor Names

Christopher Lange0

Rajinder Singh0

Sreenivas Punna0

Penglie Zhang0

Ju Yang0

Date of Patent

October 5, 2021

Patent Application Number

202001140

Date Filed

January 14, 2020

Patent Citations Received

‌

US Patent 11872217 Indanes as PD-L1 inhibitors

‌

US Patent 11691985 Macrocyclic immunomodulators

‌

US Patent 11708326 Immunomodulator compounds

‌

US Patent 11759458 Indane-amines as PD-L1 antagonists

‌

US Patent 11426364 Immunomodulator compounds

‌

US Patent 11866429 Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases

Patent abstract

Compounds are provided that are useful as immunomodulators. The compounds have the Formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11135210 Indane-amines as PD-L1 antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API